Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael F Verderame

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Neuropeptides|November 11, 2003
The expression and function of the OGF-OGFr axis - a tonically active negative regulator of growth - in COS cellsIan S Zagon, Michael F Verderame, Patricia J McLaughlin
Cell|December 14, 2011
Interdisciplinary graduate education: a case studySarah K Bronson, Michael F Verderame, Ralph L Keil
Breast Cancer Research and Treatment|March 3, 2007
Activation of protein kinase A (PKA) signaling mitigates the antiproliferative and antiinvasive effects of alpha-difluoromethylornithine in breast cancer cellsHaifang Xu, Sharlene Washington, Michael F Verderame, et al.
Molecular Endocrinology (Baltimore, Md.)|February 19, 2005
Follicle-stimulating hormone induction of ovarian insulin-like growth factor-binding protein-3 transcription requires a TATA box-binding protein and the protein kinase A and phosphatidylinositol-3 kinase pathwaysElimelda Moige Ongeri, Michael F Verderame, James M Hammond
Cancer Research|December 3, 2005
Interaction between Polyamines and the Mitogen-Activated Protein Kinase Pathway in the Regulation of Cell Cycle Variables in Breast Cancer CellsXin Hu, Sharlene Washington, Michael F Verderame, et al.
Molecular and Cellular Endocrinology|September 25, 2007
The TATA binding protein associated factor 4b (TAF4b) mediates FSH stimulation of the IGFBP-3 promoter in cultured porcine ovarian granulosa cellsElimelda Moige Ongeri, Michael F Verderame, James M Hammond
Breast Cancer Research and Treatment|December 22, 2007
Role of non-receptor and receptor tyrosine kinases (TKs) in the antitumor action of alpha-difluoromethylornithine (DFMO) in breast cancer cellsHaifang Xu, Sharlene Washington, Michael F Verderame, et al.
Brain Research. Brain Research Reviews|March 14, 2002
The biology of the opioid growth factor receptor (OGFr)Ian S Zagon, Michael F Verderame, Patricia J McLaughlin
Endocrinology|January 13, 2004
Insulin-like growth factor-binding protein-3 in porcine ovarian granulosa cells: gene cloning, promoter mapping, and follicle-stimulating hormone regulationE Moige Ongeri, Qin Zhu, Michael F Verderame, et al.
Molecular Biology of the Cell|October 17, 2008
The OGF-OGFr axis utilizes the p16INK4a and p21WAF1/CIP1 pathways to restrict normal cell proliferationFan Cheng, Patricia J McLaughlin, Michael F Verderame, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Neuropeptides|November 11, 2003
The expression and function of the OGF-OGFr axis - a tonically active negative regulator of growth - in COS cellsIan S Zagon, Michael F Verderame, Patricia J McLaughlin
Cell|December 14, 2011
Interdisciplinary graduate education: a case studySarah K Bronson, Michael F Verderame, Ralph L Keil
Breast Cancer Research and Treatment|March 3, 2007
Activation of protein kinase A (PKA) signaling mitigates the antiproliferative and antiinvasive effects of alpha-difluoromethylornithine in breast cancer cellsHaifang Xu, Sharlene Washington, Michael F Verderame, et al.
Molecular Endocrinology (Baltimore, Md.)|February 19, 2005
Follicle-stimulating hormone induction of ovarian insulin-like growth factor-binding protein-3 transcription requires a TATA box-binding protein and the protein kinase A and phosphatidylinositol-3 kinase pathwaysElimelda Moige Ongeri, Michael F Verderame, James M Hammond
Cancer Research|December 3, 2005
Interaction between Polyamines and the Mitogen-Activated Protein Kinase Pathway in the Regulation of Cell Cycle Variables in Breast Cancer CellsXin Hu, Sharlene Washington, Michael F Verderame, et al.
Molecular and Cellular Endocrinology|September 25, 2007
The TATA binding protein associated factor 4b (TAF4b) mediates FSH stimulation of the IGFBP-3 promoter in cultured porcine ovarian granulosa cellsElimelda Moige Ongeri, Michael F Verderame, James M Hammond
Breast Cancer Research and Treatment|December 22, 2007
Role of non-receptor and receptor tyrosine kinases (TKs) in the antitumor action of alpha-difluoromethylornithine (DFMO) in breast cancer cellsHaifang Xu, Sharlene Washington, Michael F Verderame, et al.
Brain Research. Brain Research Reviews|March 14, 2002
The biology of the opioid growth factor receptor (OGFr)Ian S Zagon, Michael F Verderame, Patricia J McLaughlin
Endocrinology|January 13, 2004
Insulin-like growth factor-binding protein-3 in porcine ovarian granulosa cells: gene cloning, promoter mapping, and follicle-stimulating hormone regulationE Moige Ongeri, Qin Zhu, Michael F Verderame, et al.
Molecular Biology of the Cell|October 17, 2008
The OGF-OGFr axis utilizes the p16INK4a and p21WAF1/CIP1 pathways to restrict normal cell proliferationFan Cheng, Patricia J McLaughlin, Michael F Verderame, et al.
Pageof 4